Bill Snyder

Alliance’s patient engagement efforts lauded

The Meharry-Vanderbilt Community Engaged Research Core received national recognition for its development of community review boards to strengthen patient-centered research.

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

Nine faculty honored with endowed chairs

Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.

Colleen Niswender

Autism Speaks grant boosts Rett syndrome research

Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome.

UCSF’s Vale set to explore mechanisms of biological motility

Ron Vale, Ph.D., Lasker Award winner and co-discoverer of the molecular “motor” kinesin, will give the next Flexner Discovery Lecture at 4 p.m. on Thursday, Jan. 30, in 208 Light Hall.

brain illustration

New approach may halt glioblastoma’s ability to grow

Vanderbilt University researchers have discovered a “backdoor” approach to blocking an enzyme that fuels the growth of glioblastoma, the most common and most fatal form of brain cancer.

1 97 98 99 100 101 115